Pharmaceutical manufacturers are facing increasing pressure to show safe and sustainable logistics. CSafe introduces Silverskin RE, a reusable thermal cover that protects products while reducing waste and carbon footprint. The cover is durable, cleanable, and adaptable to global supply chains, supporting temperature control for various pharmaceuticals.

The cold chain industry consumes 5% of the world’s energy and produces significant greenhouse gas emissions. The pharmaceutical cold chain is especially carbon-intensive, with studies suggesting it emits 55% more greenhouse gases than the automotive sector. Waste is another issue, with biopharma producing 300 million tons of plastic waste annually.

The World Health Organization estimates that up to 50% of vaccines were lost due to cold-chain failures before COVID-19. CSafe’s Silverskin RE launch aligns with the growing demand for sustainable cold chain packaging, with the global market projected to reach $63.3 billion by 2033. This innovation aims to reduce waste, emissions, and costs.

The pharmaceutical industry contributes to approximately 4.4% of total greenhouse emissions, with transportation, manufacturing, and packaging being major drivers. CSafe’s Silverskin RE offers an alternative to single-use thermal covers, providing reliability while reducing waste and emissions over time. The reusable cover supports temperature control for various pharmaceutical products.

Read more at Yahoo Finance: CSafe launches new reusable thermal cover for pharmaceutical manufacturers